Analysis of development trends at the pharmaceutical market of the Republic of Kazakhstan
Keywords:medicines, pharmaceutical market, strategic SWOT matrix analysis, pharmaceutical industry
Aim. To identify the trends of the pharmaceutical market of the Republic of Kazakhstan, its characteristics, problems and development prospects.
Materials and methods. The statistic data and the results of questionnaire, as well as the logical, analysis and synthesis, mathematical-statistical and analytical-comparative and questioning methods were used.
Results. Based on the analysis of the statistic data the dynamics of the volume of the pharmaceutical market of the Republic of Kazakhstan has been analyzed, it indicates a decrease in the rate of its growth; moreover, orientation on the own producers of medicines and increase in volumes of export of pharmaceutical products have been determined. The distribution of imports and exports of pharmaceutical products by countries has been considered. The main importers are Germany, France and Russia in value terms, while India, China, Germany, France and CIS countries are importers in physical terms. Export pharmaceutical products from Kazakhstan takes place in Russia (24 %), Mongolia (19 %), the Netherlands (13 %), Turkmenistan (12 %), Japan (37 %), Latvia (8 %) other countries (15 %). Based on the questionnaire of pharmacy specialists the SWOT-analysis strategic matrix of the pharmaceutical industry of the Republic of Kazakhstan has been built.
Conclusions. According to the results of the study of statistical data the main trends in development of the pharmaceutical market of the Republic of Kazakhstan have been determined. Based on the SWOT-analysis strategic matrix built the strengths and weaknesses, external opportunities and threats for the pharmaceutical industry of the Republic of Kazakhstan have been revealed, and the directions of its development have been suggested.
Global healthcare sector outlook. (2018). Available at: https://www2.deloitte.com/ru/ru/pages/life-sciences-and-healthcare/articles/ 2017/global-health-care-sector-outlook.html 2. IMS Health Market Prognosis. Available at: http://www.imsbrogancapabilities.com/pdf/consulting-market-prognosis.pdf 3. Evaluate Pharma, 2015, World Preview 2015 outlook to 2020. Available at : http://www.evaluategroup.com/ public/reports/evaluatepharma-world-preview-2015.aspx 4. WHO. Available at: http://www.who.int/ru/ 5. Kazakhstan Industry Development Institute. Available at: www.kidi.gov.kz 6. V yanvare-aprele 2017 hoda v strukture importa lekarstv v Kazakhstan lidirovali Indiia i Kitai. Available at: https://www.pharm.reviews/analitika/item/2182-v-yanvare-aprele-2017-goda-v-strukture-importa-lekarstv-v-kazakhstan-lidiruyut-indiya-i-kitaj 7. Gruppa kompanii “Remedium”. Available at: http://www.remedium.ru/about/iia.php 8. Baimbetova, O. (2016). Farmatsevticheskoe obozrenie Kazahstana, 3, 20–28. 9. Agentstvo RK po statistike. Available at: http://stat.ivisa.com/Pages/default.aspx 10. Ministerstvo zdravoohraneniya Respubliki Kazahstana. Available at: http://www.mz.gov.kz/ru 11. AO “Reitingovoe agenstvo RFCA”. Available at: http://rfcaratings.kz/ 12. Farmrynok Kazahstana. Kratkaya analiticheskaya spravka ot BMI. (2016). Farmatsevticheskoe obozrenie Kazahstana, 2, 17–21. 13. Vi-ortis. Available at: https://www.viortis.kz/ 14. Baimbetova, O. (2016). Farmatsevticheskoe obozrenie Kazahstana. Available at : https://pharm.reviews/analitika/item/1418-aptechnye-prodazhi-gls-v-kazakhstane-itogi-i-polugodiya-2016-goda 15. Obzor farmatsevticheskogo rynka Kazahstana. (2016). Available at: https://www.upharma-c.com/ru/news/146-kazakh-pharmaceutical-market-short-review-2016
Copyright (c) 2018 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).